Cited by 29Health Policy Implementation ScienceGlobal Cancer Incidence and ScreeningWomen's cancer prevention and management

A non-randomized controlled stepped wedge trial to evaluate the effectiveness of a multi-level mammography intervention in improving appointment adherence in underserved women

Open access
Highfield, L., Rajan, S.S., Valerio, M.A., Walton, G., Fernandez, M.E., Bartholomew, L.K.·2015·Implementation Science

Abstract

BACKGROUND: Considerable racial and socio-economic disparities exist in breast cancer. In spite of the existence of numerous evidence-based interventions (EBIs) aimed at reducing breast cancer screening barriers among the underserved, there is a lack of uptake or sub-optimal uptake of EBIs in community and clinical settings. This study evaluates a theoretically based, systematically designed implementation strategy to support adoption and implementation of a patient navigation-based intervention, called Peace of Mind Program (PMP), aimed at improving breast cancer screening among underserved women. METHODS/DESIGN: The PMP will be offered to federally qualified health centers and charity clinics in the Greater Houston area using a non-randomized stepped wedge design. Due to practical constraints of implementing and adopting in the real-world, randomization of start times and blinding will not be used. Any potential confounding or bias will be controlled in the analysis. Outcomes such as appointment adherence, patient referral to diagnostics, time to diagnostic referral, patient referral to treatment, time to treatment referral, and budget impact of the intervention will be assessed. Assessment of constructs from the consolidated framework for implementation research (CFIR) will be assessed during implementation and at the end of the study (sustainment) from each participating clinic. Data will be analyzed using descriptive statistics (chi-square tests) and generalized estimating equations (GEE). DISCUSSION: While parallel group randomized controlled trials (RCT) are considered the gold standard for evaluating EBI efficacy, withholding an effective EBI in practice can be both unethical and/or impractical. The stepped wedge design addresses this issue by enabling all clinics to eventually receive the EBI during the study and allowing each clinic to serve as its own control, while maintaining strong internal validity. We expect that the PMP will prove to be a feasible and successful strategy for reducing appointment no-shows in underserved women. CLINICAL TRIALS REGISTRATION NUMBER: NCT02296177.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13012-015-0334-x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The stepped-wedge design is a quasi-experimental design commonly used to evaluate organization-wide interventions.

    “The stepped-wedge is a quasi-experimental design commonly used to evaluate organization-wide interventions”

    From Improving relationship quality in group care settings: The impact of implementing the CARE model (2020) · cites this paper as Highfield et al., 2015

    Methods > Trial design describes this study as a non-randomized stepped-wedge evaluation in which clinics implement the intervention at staggered times. That supports the design as an example for evaluating a clinic-level intervention, but the paper does not establish that stepped-wedge designs are commonly used for organization-wide interventions or that they are necessarily quasi-experimental; it also discusses randomized stepped-wedge trials. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. [1]Bradley CJ Given CW Roberts C Disparities in cancer diagnosis and survival Cancer 2001 91 178 88 10.1002/1097-0142(20010101)91:1<178::AID-CNCR23>3.0.CO;2-S 11148575 · DOI
  2. [2]Gordon NH Crowe JP Brumberg DJ Berger NA Socioeconomic factors and race in breast cancer recurrence and survival Am J Epidemiol 1992 135 609 18 1580237
  3. [3]Byers TE Wolf HJ Bauer KR Bolick-Aldrich S Chen VW Finch JL The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study Cancer 2008 113 582 91 10.1002/cncr.23567 18613122 · DOI
  4. [4]Farley TA Flannery JT Late-stage diagnosis of breast cancer in women of lower socioeconomic status: public health implications Am J Public Health 1989 79 1508 12 10.2105/AJPH.79.11.1508 2817162 PMC1349803 · DOI
  5. [5]Ayanian JZ Kohler BA Abe T Epstein AM The relation between health insurance coverage and clinical outcomes among women with breast cancer N Engl J Med 1993 329 326 31 10.1056/NEJM199307293290507 8321261 · DOI
  6. [6]Bradley CJ Given CW Roberts C Re: race, socioeconomic status, and breast cancer treatment and survival J Natl Cancer Inst 2002 94 490 6 10.1093/jnci/94.7.490 11929949 · DOI
  7. [7]Schueler KM Chu PW Smith-Bindman R Factors associated with mammography utilization: a systematic quantitative review of the literature J Women’s Health 2008 17 9 1477 98 10.1089/jwh.2007.0603 18954237 · DOI
  8. [8]Onitilo AA Engel JM Liang H Stankowski RV Miskowiak DA Mammography utilization: patient characteristics and breast cancer stage at diagnosis Am J Roentgenol 2013 201 5 1057 63 10.2214/AJR.13.10733 23952790 · DOI
  9. [9]Fayanju OM Jeffe DB Tappenden JR Beers CE Drake BF Gao F Breast cancer presentation in an urban health care safety net system Mo Med 2012 109 5 405 23097949 PMC3763503
  10. [10]Wang F McLafferty S Escamilla V Luo L Late-stage breast cancer diagnosis and health care access in illinois Prof Geogr 2008 60 1 54 69 10.1080/00330120701724087 18458760 PMC2367325 · DOI
  11. [11]Rajan SS Begley CE Highfield LD Kim B Survival benefits of treatment access among underserved breast cancer patients diagnosed through the Texas breast and cervical cancer services program J Public Health Manag Pract 2015 21 5 477 86 10.1097/PHH.0000000000000255 25794245 · DOI
  12. [12]Rajan SS Begley CE Kim B Breast cancer stage at diagnosis among medically underserved women screened through the Texas breast and cervical cancer services Popul Health Manag 2014 17 4 202 10 10.1089/pop.2013.0079 24921895 · DOI
  13. [13]Spitler HD Mayo RM Parker VG Patterns of breast, cervical, colorectal, and prostate cancer in the Appalachian region of South Carolina Ethnicity Disease 2000 11 1 51 9 11289252
  14. [14]Davidson PL Bastani R Nakazono TT Carreon DC Role of community risk factors and resources on breast carcinoma stage at diagnosis Cancer 2005 103 922 30 10.1002/cncr.20852 15651072 · DOI
  15. [15]Baicker K, Chandra A, Skinner JS, Wennberg JE. Who you are and where you live: how race and geography affect the treatment of medicare beneficiaries. Health Aff (Milwood). 2004;suppl:VAR33–44. 15471775
  16. [16]Harris JR Cheadle A Hannon PA Forehand M Lichiello P Mahoney E A framework for disseminating evidence-based health promotion practices Prev Chronic Dis 2012 9 E22 10.5888/pcd9.120126 22172189 PMC3277406 · DOI
  17. [18]Rogers EM Diffusion of innovations 2003 New York, NY, USA Free Press
  18. [20]Highfield L Bartholomew LK Hartman MA Ford MM Balihe P Grounding evidence-based approaches to cancer prevention in the community: a case study of mammography barriers in underserved African American women Health Promot Pract 2014 15 6 904 14 10.1177/1524839914534685 24876632 PMC4216624 · DOI
  19. [21]Yano EM Green LW Glanz K Ayanian JZ Mittman BS Chollette V Implementation and spread of interventions into the multilevel context of routine practice and policy: implications for the cancer care continuum J Natl Cancer Inst Monogr 2012 2012 44 86 99 10.1093/jncimonographs/lgs004 22623601 PMC3482959 · DOI
  20. [22]Stetler CB McQueen L Demakis J Mittman BS An organizational framework and strategic implementation for system-level change to enhance research-based practice: QUERI series Implement Sci 2008 3 1 1 11 10.1186/1748-5908-3-1 18510750 PMC2430586 · DOI · Paper page
  21. [23]Ahmed SM Palermo AS Community engagement in research: frameworks for education and peer review Am J Public Health 2010 100 8 1380 7 10.2105/AJPH.2009.178137 20558798 PMC2901283 · DOI · Paper page
  22. [24]Taplin SH Price RA Edwards HM Foster MK Breslau ES Chollette V Introduction: understanding and influencing multilevel factors across the cancer care continuum J Natl Cancer Inst Monogr 2012 2012 44 2 10 10.1093/jncimonographs/lgs008 22623590 PMC3482968 · DOI
  23. [25]Allen CL Harris JR Hannon PA Parrish AT Hammerback K Craft J Opportunities for improving cancer prevention at federally qualified health centers J Cancer Educ 2014 29 1 30 7 10.1007/s13187-013-0535-4 23996232 PMC3920058 · DOI
  24. [27]Cialdella-Kam L Parichart SM Bispeck K Silverman S Bernstein L Krawiec V Implementing cancer prevention into clinical practice J Cancer Educ 2012 27 2 136 43 10.1007/s13187-012-0331-6 PMC4126604 22367592 · DOI
  25. [28]Taplin SH Haggstrom D Jacobs T Determan A Granger J Montalvo W Implementing colorectal cancer screening in community health centers: addressing cancer health disparities through a regional cancer collaborative Med Care 2008 46 S74 83 10.1097/MLR.0b013e31817fdf68 18725837 · DOI
  26. [29]Lipkus IM Kuchibhatla M McBride CM Bosworth HB Pollak KI Siegler IC Relationships among breast cancer perceived absolute risk, comparative risk, and worries Cancer Epidemiol Biomark Prev 2000 9 9 973 5 11008917
  27. [30]Highfield L, Hartman, MA, Mullen PD, Rodriquez S. Fernandez ME, Bartholomew LK. Intervention mapping to adapt evidence-based interventions for use in practice: increasing mammography among African American women in a practice setting. Biomed Res Int. 2015; Article ID 160103 in press PMC4637430 26587531
  28. [31]Highfield L, Hartman MA, Bartholomew LK, Balihe P, Ausborn VA. Evaluation of the effectiveness and implementation of an adapted evidence-based mammography intervention for African American women. Biomed Res Int. 2015; Article ID 240240, in press PMC4609333 26504790
  29. [32]Woertman W de Hoop E Moerbeek M Zuidema SU Gerritsen DL Teerenstra S Stepped wedge designs could reduce the required sample size in cluster randomized trials J Clin Epidemiol 2013 66 7 752 8 10.1016/j.jclinepi.2013.01.009 23523551 · DOI
  30. [33]Hade EM Murray DM Pennell ML Rhoda D Paskett ED Champion VL Intraclass correlation estimates for cancer screening outcomes: estimates and applications in the design of group-randomized cancer screening studies JNCI Monographs 2010 40 97 103 10.1093/jncimonographs/lgq011 PMC2924625 20386058 · DOI
  31. [34]Wells KJ Luque JS Miladinovic B Vargas N Asvat Y Roetzheim RG Do community health worker interventions improve rates of screening mammography in the United States? A systematic review Cancer Epidemiol Biomark Prev 2011 20 8 1580 98 10.1158/1055-9965.EPI-11-0276 PMC3153589 21653645 · DOI
  32. [35]Fernández ME Melvin CL Leeman J Ribisl KM Allen JD Kegler MC The cancer prevention and control research network: an interactive systems approach to advancing cancer control implementation research and practice Cancer Epidemiol Biomark Prev 2014 23 11 2512 21 10.1158/1055-9965.EPI-14-0097 PMC6013073 25155759 · DOI
  33. [36]Liang S Kegler M Carvalho M Fernandez M Weiner B Jacobs S Measuring constructs from the consolidated framework for implementation research in the context of increasing colorectal cancer screening at community health centers Implement Sci 2015 10 Suppl 1 A10 10.1186/1748-5908-10-S1-A10 · DOI
  34. [37]Fernandez ME Shuting L Jacobs SR Taplin SH Weiner BJ Pressing ahead: developing and testing of new measures in implementation science Implement Sci 2015 10 Suppl 1 A14 10.1186/1748-5908-10-S1-A14 · DOI
  35. [38]Liang KY Zeger S Longitudinal data analysis using generalized linear models Biometrika 1986 73 1 13 22 10.1093/biomet/73.1.13 · DOI · Paper page
  36. [40]Mauskopf JA Earnshaw S Mullins CD Budget impact analysis: review of the state of the art Expert Rev Pharmacoecon Outcomes Res 2005 5 1 65 79 10.1586/14737167.5.1.65 19807561 · DOI
  37. [41]Mauskopf JA Sullivan SD Annemans L Caro J Mullins CD Nuijten M Principles of good practice for budget impact analysis: report of the ISPOR task force on good research practices—budget impact analysis Value Health 2007 10 5 336 47 10.1111/j.1524-4733.2007.00187.x 17888098 · DOI
  38. [42]Hawkins NG Sanson-Fisher RW Shakeshaft A D’Este C Green LW The multiple baseline design for evaluating population-based research Am J Prev Med 2007 33 2 162 8 10.1016/j.amepre.2007.03.020 17673105 · DOI
  39. [43]De Allegri M Pokhrel S Becher H Dong H Mansmann U Kouyaté B Step-wedge cluster-randomised community-based trials: an application to the study of the impact of community health insurance Health Res Policy Syst 2008 6 10 6 10 18945332 PMC2583992
  40. [44]Rhoda DA Murray DM Andridge RR Pennell ML Hade EM Studies with staggered starts: multiple baseline designs and group-randomized trials Am J Public Health 2011 101 11 2164 10.2105/AJPH.2011.300264 21940928 PMC3222403 · DOI · Paper page
  41. [45]Hussey MA Hughes JP Design and analysis of stepped wedge cluster randomized trials Contemp Clin Trials 2007 28 182e91 10.1016/j.cct.2006.05.007 16829207 · DOI

Cited by

Sorted by citations

Authors
Highfield, L., Rajan, S. S., Valerio, M. A., Walton, G., Fernandez, M. E., & Bartholomew, L. K.
Affiliations
The University of Texas Health Science Center at Houston (US)
Corresponding author
Highfield, L.
Venue
Implementation Science
Published
2015-10-14
Volume
10
Issue
1
Pages
143-143
ISSN
1748-5908 (ISSN-L)
OpenAlex
W1891876852
Cited by
29
References
5
Citations by year
2026: 2 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 8 · 2020: 4 · 2019: 3 · 2018: 2 · 2016: 1
FWCI
1.70
Type
journal article
Language
en
Open access
Locations
  • Implementation Science (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Agency for Healthcare Research and Quality (1R18HS023255-01)
Topics
  • Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Keywords
mammography, breast cancer screening, appointment adherence, patient navigation, underserved women, racial and socioeconomic disparities, federally qualified health centers, implementation strategies, stepped wedge design, Consolidated Framework for Implementation Research, budget impact
MeSH terms
Adult, Appointments and Schedules, Breast Neoplasms, Female, Humans, Mammography, Medical Assistance, Middle Aged, Patient Compliance, Referral and Consultation, Research Design, Socioeconomic Factors, Texas, Time Factors, Vulnerable Populations, Early Detection of Cancer, Safety-net Providers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review